Acumen Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Acumen Pharmaceuticals, Inc.

Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal a…

Biotechnology
US, Charlottesville [HQ]

Cash Flow Statements

Loading...
End of ABOS's Analysis
CIK: 1576885 CUSIP: 00509G209 ISIN: US00509G2093 LEI: - UEI: -
Secondary Listings
ABOS has no secondary listings inside our databases.